These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 22110661)

  • 21. Adhesion molecules--The lifelines of multiple myeloma cells.
    Katz BZ
    Semin Cancer Biol; 2010 Jun; 20(3):186-95. PubMed ID: 20416379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of bone lesions in multiple myeloma.
    Bataille R; Chappard D; Klein B
    Hematol Oncol Clin North Am; 1992 Apr; 6(2):285-95. PubMed ID: 1582975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cytokines and myeloma bone disease].
    Abe M
    Clin Calcium; 2014 Jun; 24(6):871-8. PubMed ID: 24870838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Notch-directed microenvironment reprogramming in myeloma: a single path to multiple outcomes.
    Colombo M; Mirandola L; Platonova N; Apicella L; Basile A; Figueroa AJ; Cobos E; Chiriva-Internati M; Chiaramonte R
    Leukemia; 2013 Apr; 27(5):1009-18. PubMed ID: 23307030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Morphogens and growth factor signalling in the myeloma bone-lining niche.
    Morris EV; Edwards CM
    Cell Mol Life Sci; 2021 May; 78(9):4085-4093. PubMed ID: 33570672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adipose, Bone, and Myeloma: Contributions from the Microenvironment.
    McDonald MM; Fairfield H; Falank C; Reagan MR
    Calcif Tissue Int; 2017 May; 100(5):433-448. PubMed ID: 27343063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple myeloma biology: lessons from the 5TMM models.
    Vanderkerken K; Asosingh K; Croucher P; Van Camp B
    Immunol Rev; 2003 Aug; 194():196-206. PubMed ID: 12846816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-cadherin-mediated interaction with multiple myeloma cells inhibits osteoblast differentiation.
    Groen RW; de Rooij MF; Kocemba KA; Reijmers RM; de Haan-Kramer A; Overdijk MB; Aalders L; Rozemuller H; Martens AC; Bergsagel PL; Kersten MJ; Pals ST; Spaargaren M
    Haematologica; 2011 Nov; 96(11):1653-61. PubMed ID: 21828122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human placenta-derived adherent cells prevent bone loss, stimulate bone formation, and suppress growth of multiple myeloma in bone.
    Li X; Ling W; Pennisi A; Wang Y; Khan S; Heidaran M; Pal A; Zhang X; He S; Zeitlin A; Abbot S; Faleck H; Hariri R; Shaughnessy JD; van Rhee F; Nair B; Barlogie B; Epstein J; Yaccoby S
    Stem Cells; 2011 Feb; 29(2):263-73. PubMed ID: 21732484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bone tissue and cancer].
    Rossi JF
    Pathol Biol (Paris); 1990 Jan; 38(1):69-79. PubMed ID: 2407992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibiting activin-A signaling stimulates bone formation and prevents cancer-induced bone destruction in vivo.
    Chantry AD; Heath D; Mulivor AW; Pearsall S; Baud'huin M; Coulton L; Evans H; Abdul N; Werner ED; Bouxsein ML; Key ML; Seehra J; Arnett TR; Vanderkerken K; Croucher P
    J Bone Miner Res; 2010 Dec; 25(12):2633-46. PubMed ID: 20533325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modeling multiple myeloma-bone marrow interactions and response to drugs in a 3D surrogate microenvironment.
    Belloni D; Heltai S; Ponzoni M; Villa A; Vergani B; Pecciarini L; Marcatti M; Girlanda S; Tonon G; Ciceri F; Caligaris-Cappio F; Ferrarini M; Ferrero E
    Haematologica; 2018 Apr; 103(4):707-716. PubMed ID: 29326121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective inhibition of matrix metalloproteinase-2 in the multiple myeloma-bone microenvironment.
    Shay G; Tauro M; Loiodice F; Tortorella P; Sullivan DM; Hazlehurst LA; Lynch CC
    Oncotarget; 2017 Jun; 8(26):41827-41840. PubMed ID: 28611279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Consequences of daily administered parathyroid hormone on myeloma growth, bone disease, and molecular profiling of whole myelomatous bone.
    Pennisi A; Ling W; Li X; Khan S; Wang Y; Barlogie B; Shaughnessy JD; Yaccoby S
    PLoS One; 2010 Dec; 5(12):e15233. PubMed ID: 21188144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computational modeling of multiple myeloma interactions with resident bone marrow cells.
    Urdeitx P; Mousavi SJ; Avril S; Doweidar MH
    Comput Biol Med; 2023 Feb; 153():106458. PubMed ID: 36599211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular profiling of bone remodeling occurring in musculoskeletal tumors.
    Nakajima K; Kidani T; Miura H
    J Orthop Res; 2021 Jul; 39(7):1402-1410. PubMed ID: 33034913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modelling the anabolic response of bone using a cell population model.
    Buenzli PR; Pivonka P; Gardiner BS; Smith DW
    J Theor Biol; 2012 Aug; 307():42-52. PubMed ID: 22579551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adipocyte-Lineage Cells Support Growth and Dissemination of Multiple Myeloma in Bone.
    Trotter TN; Gibson JT; Sherpa TL; Gowda PS; Peker D; Yang Y
    Am J Pathol; 2016 Nov; 186(11):3054-3063. PubMed ID: 27648615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Positive Feedback Loops Between Inflammatory, Bone and Cancer Cells During Metastatic Niche Construction.
    Kianercy A; Pienta KJ
    Adv Exp Med Biol; 2016; 936():137-148. PubMed ID: 27739046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Link between osteoclastogenesis, angiogenesis and myeloma expansion].
    Abe M
    Clin Calcium; 2008 Apr; 18(4):473-9. PubMed ID: 18379029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.